NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · IEX Real-Time Price · USD
6.73
+0.04 (0.60%)
Jun 25, 2024, 1:53 PM EDT - Market open

NeuroPace Revenue

NeuroPace had revenue of $69.07M in the twelve months ending March 31, 2024, with 42.07% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $18.12M with 25.23% year-over-year growth. In the year 2023, NeuroPace had annual revenue of $65.42M with 43.72% growth.

Revenue (ttm)
$69.07M
Revenue Growth
+42.07%
P/S Ratio
2.82
Revenue / Employee
$381,619
Employees
181
Market Cap
193.90M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202365.42M19.90M43.72%
Dec 31, 202245.52M337.00K0.75%
Dec 31, 202145.18M4.05M9.83%
Dec 31, 202041.14M4.17M11.27%
Dec 31, 201936.97M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 321.52M
Coherus BioSciences 301.87M
Akebia Therapeutics 187.23M
OptimizeRx 78.21M
2seventy bio 71.20M
Butterfly Network 68.08M
EDAP TMS 65.80M
Genfit 42.42M
Revenue Rankings